# 11C Topotecan PET Imaging

> **NCT00253461** · EARLY_PHASE1 · TERMINATED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 7 (actual)

## Conditions studied

- Lung Cancer
- Metastatic Cancer
- Ovarian Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **PROCEDURE:** computed tomography
- **PROCEDURE:** positron emission tomography
- **RADIATION:** 11C topotecan
- **RADIATION:** fludeoxyglucose F 18

## Key facts

- **NCT ID:** NCT00253461
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-12
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Drugs unavailable:unable to make radioactive topotecan
- **Last updated:** 2012-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00253461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00253461, "11C Topotecan PET Imaging". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00253461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*